Laurus Labs Ltd. Share Price

Laurus Labs' Rs 12.09 crore investment in KRPL

Laurus Labs maintains a strong higher-high structure!

Laurus Labs maintains a strong higher-high structure Laurus Labs Limited (NSE: LAURUSLABS) remains in a cyclical uptrend, with the stock continuing to form higher highs and higher lows. Technical analysts have identified ₹1,954 as key support and ₹2,200 as the next upside target. Why it matters The stock has repeatedly attracted buying interest on dips toward its 20-day EMA. Its 20-EMA and 50-EMA are also in a bullish crossover, supporting the broader positive structure. The setup is particularly notable because the wider Indian market is under pressure. The Nifty 50 fell 1.64% on October 8 to 22,231.8, its lowest close in 18 months. When the index is weak, stocks that continue to defend important moving averages can offer better relative-strength setups. My view The ₹1,954 area is the key level I would monitor. Holding this zone keeps the higher-high, higher-low structure intact. A sustained move toward ₹2,200 would strengthen the bullish setup. A decisive break below ₹1,954 would weaken the current structure.

PHARMA SECTOR SHOWING SUPER STRENGTH AMID WEAKER MARKETS

One interesting trend in the current market is the relative strength being displayed by Pharma stocks. During the COVID period, Pharma stocks had a completely different story. Despite many companies having strong fundamentals and robust businesses, the sector witnessed significant selling and several quality Pharma stocks were beaten down heavily once the initial COVID euphoria faded. Fast forward to today — the scenario looks very different. While the broader market is facing pressure, several Pharma stocks are holding their ground and continuing to show strong price action. Stocks like Divi’s Labs, Laurus Labs, Torrent Pharma, Zydus Lifesciences, Sun Pharma and Lupin are among the names showing encouraging strength. For me, the important takeaway is not simply that Pharma is rising — it is that Pharma is showing strength when the broader market is weak. That kind of relative strength often deserves attention. When the market becomes volatile, sectors that refuse to participate in the downside can potentially become the leaders when market sentiment improves. Pharma is definitely a sector I would keep on the radar for momentum and swing-trading opportunities.

Granules India targets ₹2,000 crore organic capex.

Granules India Limited

Laurus Labs invests Rs 12.09 crore in Kurnool Renewables

Laurus Labs Limited

Stocks showing >25% profit growth - worth keeping on radar

• Dixon Technologies • Trent • CG Power • Dr Reddy’s Labs • Torrent Power • Oil India • Apar Industries • Voltas • IndusInd Bank • Marico • Vishal Mega Mart • NTPC Green Energy • Balkrishna Industries • HDFC AMC • Laurus Labs • Radico Khaitan • Alanta Pharma Not saying all will run… But strong profit growth usually gets noticed by the market sooner or later. Which one is already on your watchlist? .